Judy DiClemente | Insight Communications IR |
Nikhil Lalwani | President and CEO |
Stephen Carey | CFO |
Vamil Divan | Guggenheim Securities |
Les Sulewski | Truist Securities |
Good morning, everyone. My name is Chelsea and I will be your conference operator. At this time, I would like to welcome everyone to ANI Pharmaceuticals Second Quarter 2023 Financial Results. [Operator Instructions] As a reminder, this conference call is being recorded today, August 9, 2023.
It is now my pleasure to turn the floor over to Ms.